Filing Flows › Quest Diagnostics (DGX) › Capital expenditures
Quest Diagnostics (DGX) capital expenditures by quarter
Quest Diagnostics' capital expenditures were $166M in Q3 2026 (third quarter 2026), +20% from Q2 2026. Over the last 7 quarters it ranged from $108M (Q2 2025) to $166M (Q3 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $166M | +20% | +15% |
| Q2 2026 | $138M | +21% | +28% |
| Q1 2026 | $114M | -28% | -3% |
| Q4 2025 | $158M | +10% | — |
| Q3 2025 | $144M | +33% | — |
| Q2 2025 | $108M | -8% | — |
| Q1 2025 | $117M | — | — |
Q3 2026 at a glance
Quest Diagnostics, Q3 2026: revenue $3.1B (+10% year over year), operating margin 15.5%, net earnings $312M, operating cash flow $611M. The chart follows the revenue to costs, profit and cash.
Questions
What is Quest Diagnostics' capital expenditures?
Quest Diagnostics' capital expenditures were $166M in Q3 2026 (third quarter 2026), +20% from Q2 2026.
How has Quest Diagnostics' capital expenditures changed?
Over the last 7 quarters it ranged from $108M (Q2 2025) to $166M (Q3 2026).